ADVANCED HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2013/059246/06) (“the Company” or “Advanced Health”) ISIN Code: ZAE000189049 JSE Code: AVL TRADING STATEMENT In terms of paragraph 3.4(b)(i) of the Listings Requirements of the JSE Limited, listed companies are required to publish a trading statement as soon as they become reasonably certain that the financial results for the next period to be reported on will differ by more than 20% from those of the comparative period. The directors of Advanced Health hereby advise shareholders that, in respect of the reviewed consolidated results for the year ended 30 June 2022, the Company expects a loss per share of 4.04 cents which is an improvement of 50.4% compared to the restated loss per share of 8.14 cents in the comparative period. The headline loss per share for the year ended 30 June 2022 is expected to be 5.89 cents compared to the headline loss per share of 6.82 cents in the comparative period, a 13.6% improvement in headline loss per share. The information in this trading statement has not been reviewed and reported on by the Company’s auditors. Pretoria. 06 September 2022 Designated Advisor Grindrod Bank Limited